AAA December 2015 – Page 15

Symic pushes series A to $40m

Lilly Ventures, the corporate venturing arm of pharmaceutical firm Eli Lilly, led a $25m extension yesterday to a series A round for US-based biotechnology company Symic that now stands at $40m. Symic raised an initial $15m in a January 2015 first tranche that was also led by Lilly Ventures. All of the first tranche’s participants… Continue reading Symic pushes series A to $40m